Prexasertib increases the sensitivity of pancreatic cancer cells to gemcitabine and S‑1

Yoshihito Morimoto(Showa Pharmaceutical University), Yutaka Masuda(Rakuno Gakuen University)
Oncology Reports
November 28, 2019
Cited by 17


Related Papers